1. Adelaide Research & Scholarship

Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.

 | 
Results 21-30 of 40 (Search time: 0.003 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2007The role of the chemokine CXCL12 in osteoclastogenesisGronthos, S.; Zannettino, A.
2003A novel CD44 antibody identifies an epitope that is aberrantly expressed on acute lymphoblastic leukaemia cellsBendall, L.; James, A.; Zannettino, A.; Simmons, P.; Gottlieb, D.; Bradstock, K.
2010Dysregulation of bone remodeling by imatinib mesylateVandyke, K.; Fitter, S.; Dewar, A.; Hughes, T.; Zannettino, A.
2010Pentosan polysulfate promotes proliferation and chondrogenic differentiation of adult human bone marrow-derived mesenchymal precursor cellsGhosh, P.; Wu, J.; Shimmon, S.; Zannettino, A.; Gronthos, S.; Itescu, S.
2010The poor response to imatinib observed in CML patients with low OCT-1 activity is not attributable to lower uptake of imatinib into their CD34⁺ cellsEngler, J.; Frede, A.; Saunders, V.; Zannettino, A.; White, D.; Hughes, T.
2005Macrophage colony-stimulating factor receptor c-fms is a novel target of imatinibDewar, A.; Cambareri, A.; Zannettino, A.; Boog, B.; Doherty, K.; Hughes, T.; Lyons, A.
2006OCT-1-mediated influx is a key determinant of the intraceflular uptake of imatinib but not nilotinib, (AMN107): reduced OCT-1 activity is the cause of low in vitro sensitivity to imatinibWhite, D.; Saunders, V.; Dang, P.; Engler, J.; Zannettino, A.; Cambareri, A.; Quinn, S.; Manley, P.; Hughes, T.
2005Stromal-derived factor-1 promotes the growth, survival, and development of human bone marrow stromal stem cellsKortesidis, A.; Zannettino, A.; Isenmann, S.; Shi, S.; Lapidot, T.; Gronthos, S.
2009A role for pericytes as microenvironmental regulators of human skin tissue regenerationPaquet- Fifield, S.; Schluter, H.; Li, A.; Aitken, T.; Gangatirkar, P.; Blashki, D.; Koelmeyer, R.; Pouliot, N.; Palatsides, M.; Ellis, S.; Brouard, N.; Zannettino, A.; Saunders, N.; Thompson, N.; Li, J.; Kaur, P.
2010Plasma adiponectin levels are markedly elevated in imatinib-treated chronic myeloid leukemia (CML) patients: A mechanism for improved insulin sensitivity in Type 2 diabetic CML patients?Fitter, S.; Vandyke, K.; Schultz, C.; White, D.; Hughes, T.; Zannettino, A.

Discover